Cell and Gene Therapy 2023

Online Symposium Summary

This inaugural event will showcase recent advances in the development of cell and gene therapies and the opportunities they provide for the treatment of disease and injury. Focus will be given to cancer immunotherapies and vaccines, stem cells, vector technologies and examples of genetic modification to treat a range of conditions.

This online symposium will cover:

Homologous recombination-based genome editing
Hematopoietic stem and progenitor cell gene therapy
Drug-adapted cancer cell lines as preclinical resistance models
Cell therapy research and development products and services
Human iPSC-based neurological disease modeling
Stem cell-based tools and processes for regenerative medicine
Enhancing the function of Tregs using cell therapies
Ultrarapid development of safe and effective pandemic vaccines
In-process measurements of critical quality attributes of CAR-T

Keynote Speaker:

Matthew-Porteus-webinarheadshot

Matthew Porteus, MD
Professor of Pediatrics
Stanford University

Speakers:

Stephanie Cherqui, PhD

Stephanie Cherqui, PhD
Professor
University of California San Diego

Martin Michaelis, PhD

Martin Michaelis, PhD
Professor of Molecular Medicine
University of Kent

Tracy Zhao
Field Application Scientist
ACROBiosystems

Stanley H. Appel, M.D.
Chair, Scientific Advisory Board and Professor
Coya Therapeutic, Inc. and Department of Neurology

Xiaowen Bai, PhD-

Xiaowen Bai, PhD
Associate Professor
Medical College of Wisconsin

Gabriella Perell, PhD
Cell and Gene Therapy Product Manager
Bio-Techne

Xi Lu, PhD
Cell and Gene Therapy Senior Scientist
Bio-Techne

Nikolai Petrovsky, PhD-

Nikolai Petrovsky, PhD
Professor of Medicine
Vaxine Pty Ltd

Yama Abassi, PhD
New Market Development
Agilent Technologies

Tamara Laskowski, PhD
Head of Clinical & Process Development
Lonza-Personalized Medicine

Habib Malik
Field Application Scientist
Bio-Techne

Kevin Holden, PhD
Head of Science
Synthego